Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson
Huberman Lab Podcast Recap
Published:
Duration: 2 hr 27 min
Guests: Dr. Alex Marson
Summary
The podcast episode discusses advancements in cancer treatment through the use of CAR T cell therapy and gene editing technologies like CRISPR. Dr. Alex Marson emphasizes the potential of harnessing the immune system to target and eliminate cancer cells, while also addressing ethical considerations...
What Happened
CAR T cells, short for chimeric antigen receptor T cells, are engineered in laboratories to specifically target and eliminate cancer cells. These cells are reintroduced into a patient's body in a manner similar to a blood transfusion, marking a significant advancement in personalized cancer treatment. Dr. Alex Marson from the University of California, San Francisco, focuses on harnessing the immune system's power to eradicate cancer, emphasizing the role of genetic reprogramming.
Gene editing, once a concept relegated to science fiction, has become a tangible reality in the fight against diseases. Technologies like CRISPR, lipid nanoparticles, and vaccines have emerged as tools to directly program cellular behavior. Dr. Marson highlights the synergy in biology, where understanding and addressing the root causes of diseases is becoming increasingly precise, leveraging advancements in DNA sequencing and gene editing.
The immune system's complexity is underscored by its division into innate and adaptive systems, with white blood cells like dendritic cells and macrophages acting as first responders. Lymphocytes, including B cells and T cells, play a pivotal role in the adaptive immune response, evolving receptors to recognize invaders. Dr. Marson explains that T cells undergo a unique selection process in the thymus, which eliminates cells recognizing self-antigens.
Cancer is fundamentally a genetic disease characterized by uncontrolled cell division due to mutations in DNA. Dr. Marson notes that cancer risk increases with age as genetic mutations accumulate over time. Environmental factors such as smoking, UV light, and certain food additives also contribute to DNA damage, elevating cancer risk.
Checkpoint inhibitors and CAR T cell therapies have shown promise, particularly in treating cancers like melanoma and some leukemias. Emily Whitehead became the first pediatric patient successfully treated with CAR T cell therapy, a milestone in cancer treatment. The therapy targets specific proteins on cancer cells, like CD19 on B cells, offering effective treatment with manageable side effects.
CRISPR technology, introduced in 2012, has revolutionized genetic editing by allowing precise modifications of DNA sequences. It has been instrumental in engineering CAR T cells not only for blood cancers but also for solid tumors. The advancement of CRISPR has sparked clinical trials for various cancers, aiming to enhance the precision and efficacy of treatments.
Dr. Marson brings attention to the ethical considerations of genetic engineering, particularly concerning germline modifications. He advocates for somatic edits that are non-heritable, emphasizing the potential risks associated with 'designer babies' and the loss of genetic diversity. Books like 'The Case Against Perfection' by Michael Sandel are referenced to explore the philosophical implications of striving for genetic 'perfection.'
Key Insights
- CAR T cells are engineered to target and destroy cancer cells by reprogramming T cells with chimeric antigen receptors. This approach has shown significant success in treating certain leukemias and lymphomas.
- CRISPR technology allows precise DNA editing, revolutionizing the treatment of genetic diseases and cancer. It has enabled the development of therapies that directly modify immune cells to enhance their cancer-fighting capabilities.
- The immune system's complexity includes the innate system, which acts as the first line of defense, and the adaptive system, which evolves to specifically target pathogens. T cells and B cells play crucial roles in this adaptive response.
- Environmental factors, such as smoking and UV exposure, are major contributors to DNA mutations that can lead to cancer. Genetic predispositions, like BRCA mutations, also significantly increase cancer risk, underscoring the importance of genetic testing.